Professor Shafi Ahmed has taken on the role of Non-Executive Director at National Clinical Insourcing (NCI)
Posted:
Recently awarded a position on the SBS framework, NCI is now positioned to support NHS partners across a diverse portfolio of services, including Breast, General Surgery, Urology, Endoscopy, GI, Gynaecology, T&O, Dermatology, Ophthalmology and ENT services. If you are interested in finding out more, please reach out to Shafi or the team directly at NCI at Info@nationalclinicalinsourcing.com.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.